<DOC>
	<DOCNO>NCT01183429</DOCNO>
	<brief_summary>The purpose study find effect , good and/or bad , combination 3F8 GM-CSF patient cancer . Antibodies make body attack tumor fight infection . 3F8 name one kind antibody . It make mouse , attack neuroblastoma people . 3F8 use safely many patient , kill cancer cell patient . One way kill cancer cell cause patient 's white blood cell attack cancer . Granulocytes one kind white blood cell . GM-CSF increase number granulocytes people , make granulocyte well able kill cancer cell .</brief_summary>
	<brief_title>3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid Consolidation First Remission After Non-Myeloablative Therapy Patients With High-Risk Neuroblastoma</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Diagnosis NB define ) histopathology ( confirm MSKCC Department Pathology ) , b ) BM metastases MIBGavid lesion ( ) plus high urine catecholamine level . Highrisk NB define riskrelated treatment guidelines1 International NB Staging System,89 i.e. , stage 4 ( age ) without ( â‰¥18 month age ) MYCN amplification , MYCNamplified stage 2 stage 3 ( age ) , MYCNamplified stage 4S . The patient first CR/VGPR conventional therapy . They measurable MIBGavid soft tissue tumor assessable response . Signed informed consent indicate awareness investigational nature program . Creatinine &gt; 3.0 mg/dL ALT , AST Alkaline Phosphatase &gt; 5.0 time upper limit normal Bilirubin &gt; 3.0 mg/dL Patients grade 3 high toxicity ( use CTCAE v3.0 ) relate cardiac , neurological , pulmonary gastrointestinal function determine physical exam . Patients must normal blood pressure age . Progressive disease History allergy mouse protein . Active lifethreatening infection . Human antimouse antibody ( HAMA ) titer &gt; 1000 Elisa units/ml . Inability comply protocol requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MAB 3F8</keyword>
	<keyword>RETINOIC ACID ( CIS-9 &amp; 13 )</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>09-159</keyword>
</DOC>